Delivery Order SPE2DB24D2205-SPE2DB24FDSJG
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation that serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies. The award is a firm fixed price delivery order for 4,563,856,643 units of BOTOX 200 with a potential value of $3,492.78 and a performance period through March 22, 2024. This award is not associated with any set-aside...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, for the provision of 200 unit BOTOX vials. The firm fixed price award, valued at $4,657.04, has a completion date of March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is not associated with any set-aside designation. Amerisourcebergen Drug Corp is also the prime contractor...
- This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, to provide Botox 200 unit vials. The order has a ceiling value of $17,463.90 and a period of performance through April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor, and this award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that runs through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $13,971.12 firm fixed price delivery order is for the provision of 200-unit vials of Botox. The contract has no set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,910.65 firm fixed price delivery order is for the provision of 200-unit vials of Botox. The award is not designated as a set-aside contract. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 200 unit vials of Botox. The $2,910.65 contract has a performance period through March 4, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) previously...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $11,642.60 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of 200 unit BOTOX vials to a location in Conshohocken, Pennsylvania by March 19, 2024. This award is part of Amerisourcebergen Drug Corp's role as the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 200 unit vials of BOTOX medication. The award, valued at $11,642.60, has a completion date of March 25, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which does not have a set-aside designation. The company also holds an indefinite delivery contract (IDC) with DLA, valued up to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BOTOX 200 unit vials to the U.S. government. The $4,657.04 firm-fixed price contract was awarded on June 26, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). This is a delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $2,328.52 firm fixed price delivery order (Contract ID: SPE2DX15D2101|SPE2DX24F51CK) by the Defense Logistics Agency (DLA) Troop Support Medical to provide BOTOX 200 unit vials. This delivery order is part of an indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDSJGDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Botox 200 unit vials. The contract is a firm fixed price delivery order with a ceiling value of $2,910.65 and a period of performance through April 30, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. In addition to this specific delivery order, Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 4/9/24 |